AAOMS Member Alerts

In order to keep effective drugs and devices available on the market for use by you and your patients, the FDA relies on the voluntary reporting of all adverse events. FDA uses the data to maintain its safety surveillance of all FDA-regulated products. Your report may be the critical action that prompts a modification in use or design of the product, improves the safety profile of the drug or device and leads to increased patient safety.

Member Alerts Date
Member Alert: Annual Meeting and Dental Implant Conference to go virtual Jun. 18, 2020
Interim message from the AAOMS President: Special Committee develops reopening protocol May. 14, 2020
Member Alert: Limited Supply of KN95 Respirators and Face Shields Available May. 07, 2020
Telehealth Resources May. 01, 2020
Member Alert: Limited supply of reusable facemasks available Apr. 21, 2020
Member Alert: AAOMS COVID-19 Webcast on April 22: Where we are and how we will move forward Apr. 17, 2020
States plead for volunteers, blood donations Apr. 13, 2020
COVID-19 Updates Apr. 10, 2020
Member Alert: Loss reminds us of our dedication, determination Apr. 05, 2020
Member Alert: SBA Accepting COVID-19 Loan Applications Mar. 30, 2020
Member Alert: Difficult times; difficult decisions. Always advocating for OMSs Mar. 24, 2020
Member Alert: COVID-19 Guidance for OMS Practices Mar. 17, 2020
Member Alert: COVID-19 Update Mar. 15, 2020
AAOMS Novel Coronavirus (COVID-19) Update Mar. 09, 2020
AAOMS Statement on Office-Based OMS Anesthesia Aug. 06, 2019
ASA Endorses Joint Statement Opposing the OMS Pediatric Anesthesia Team Model Jul. 29, 2019
FDA restricts use of codeine, tramadol in children Jul. 31, 2017
Cantrell Drug Company announces recall Jul. 31, 2017
Member Alert: Hospira Issues a Voluntary Nationwide Recall For One Lot Of 0.25% Bupivacaine Hydrochloride Injection, USP Due to The Presence Of Particulate Matter Within a Single Vial Aug. 05, 2016
Member Alert:CDC Webinar Series Addresses Guidelines for Prescribing Opioids Jun. 16, 2016
Member Alert: New Safety Warnings Added to Prescription Opioid Medications Mar. 24, 2016
AAOMS Announces New Executive Director Feb. 08, 2016
FDA Safety Alert: Acetaminophen Tablets by Medline Industries: Recall - Mislabeling with Incorrect Strength Oct. 16, 2015
Member Alert: Alere Initiates Voluntary URGENT PRODUCT RECALL of Alere INRatio 2 PT/INR Professional Test Strips Mar. 16, 2015
Member Alert: Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, 250 mL Due to Particulate Matter Jan. 26, 2015
Member Alert: Reports of Serious Injuries from Bone Graft Substitutes Jan. 21, 2015
Member Alert: AAOMS & ADA respond to LA Times article Jan. 13, 2015
Member Alert: Heart Sync Inc. Issues Voluntary Device Correction for Multi-function Defibrillation Electrodes Dec. 08, 2014
Member Alert: Resources for addressing possible Ebola infected patients Oct. 16, 2014
Member Alert: ACS “Surgical Protocol for Possible or Confirmed Ebola Cases” heading Oct. 15, 2014
Member Alert: DePuy Synthes Craniomaxillofacial Distraction System: Class I Recall - May Reverse Directions After Surgery Aug. 28, 2014
Member Alert: FDA Reschedules Hydrocodone Combination Products from Schedule III to Schedule II Aug. 22, 2014
Member Alert: Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates Aug. 21, 2014
Member Alert: Baxter Initiates Voluntary Worldwide Recall of 4 Lots of IV Solutions Due to Presence Jul. 28, 2014
Member Alert: Manufacturers increasing cost of scarce saline solution Jul. 03, 2014
Member Alert: Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates Apr. 22, 2014
Member Alert: Glycopyrrolate Injection Shortage Feb. 10, 2014
Member Alert: Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement - Recommendation to Discontinue Prescribing and Dispensing Jan. 15, 2014
Member Alert: FDA issues safety communication on HeartStart automated external defibrillators from Philips Healthcare Dec. 11, 2013
Member Alert: FDA to submit formal recommendation to reclassify hydrocodone combination products into Schedule II Oct. 25, 2013
Member Alert: Pallimed Solutions, Inc. Sterile Compound Products: Recall - Visible Particulates Observed Apr. 01, 2013
Member Alert: FDA Issues Class 1 Recall: Verathon GlideScope Video Laryngoscope - Breaking Across the Tip of the Blade Dec. 17, 2012
Member Alert: FDA reports safety risk from tissue recovered at the Pacific Coast Tissue Bank of Los Angeles, CA Nov. 16, 2012
Member Alert: FDA Recalls Accutron, Inc. Ultra PC% Cabinet Mount Flowmeters for Nitrous Oxide-Oxygen Sedation Systems Oct. 25, 2012
Member Alert: I-Flow ON-Q Pump with ONDEMAND Bolus Button: Class I Recall - Risk of Continuous Infusion at a Rate Greater Than Expected Sep. 05, 2012